Camara-Lemarroy et al. (2021) similarly reported high serum I-FABP and D-lactate concentrations in individuals with acute ischemic stroke (AIS), confirming I-FABP’s potential as a promising biomarker. Here, FABP2 is linked to androgen insensitivity syndrome.